Back
Nippon Telegraph & Telephone Vs. Spyre Therapeutics Industry Stock Comparison
Buy
61
NTTYY
Nippon Telegraph & Telephone
Last Price:
24.06
Seasonality Move:
0.76%
Buy
80
SYRE
Spyre Therapeutics
Last Price:
34.13
Seasonality Move:
2.56%
Buy
61
Nippon Telegraph & Telephone (NTTYY)
is a Buy
Is Nippon Telegraph & Telephone a Buy, Sell or Hold?
- The current Nippon Telegraph & Telephone [NTTYY] share price is $24.06. The Score for NTTYY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- NTTYY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $34.15. The Score for SYRE is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTTYY Stock Price Chart
What is Nippon Telegraph & Telephone's stock price today?
-
The Nippon Telegraph & Telephone share price today is $24.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTTYY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $34.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTTYY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 26.04 | Sell |
| Chaikin Money Flow: | 85423 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.65 - 25.97) | Sell |
| Bollinger Bands (100): | (24.11 - 26.27) | Sell |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.18 | Buy |
| Relative Strength Index (14 RSI): | 69.23 | Buy |
| Chaikin Money Flow: | 370539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.56 - 31.32) | Buy |
| Bollinger Bands (100): | (25.35 - 31.93) | Buy |
NTTYY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.58 | Sell |
| 20-day SMA: | 25.09 | Sell |
| 50-day SMA: | 25.81 | Sell |
| 200-day SMA: | 27.16 | Sell |
| 8-day EMA: | 24.53 | Sell |
| 20-day EMA: | 25.01 | Sell |
| 50-day EMA: | 25.45 | Sell |
| 200-day EMA: | 26.6 | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.22 | Buy |
| 20-day SMA: | 29.4 | Buy |
| 50-day SMA: | 28.35 | Buy |
| 200-day SMA: | 30.28 | Buy |
| 8-day EMA: | 31.69 | Buy |
| 20-day EMA: | 30.14 | Buy |
| 50-day EMA: | 29.15 | Buy |
| 200-day EMA: | 27.73 | Buy |
Nippon Telegraph & Telephone Earnings Growth & NTTYY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.01 per share, and a decrease next year of $0.09 per share.
Nippon Telegraph & Telephone Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||